Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/2/07 → 12/31/15 |
Funding
- Frontier Science and Technology Research Foundation (PCOE5103-00 // PCOE5103-00)
- Genentech, Inc (PCOE5103-00 // PCOE5103-00)
ECOG PCO-RL: E5103: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
- Yang, Ximing J (PD/PI)
Project: Research project